Efficacy and Safety of Adipose Stem Cell Culture Supernatant Extract for Skin Ulcers

akagawa Masahiro0 个研究点目标入组 80 人开始时间: 2023年6月23日最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•1. men and women between 18 and 90 years of age
•2. patients with various types of skin ulcers (excluding head and face)
•3. patients with skin ulcers with a maximum diameter of 1 cm or more but less than 9 cm
•4. patients whose consent to participate in this study has been obtained by signing a consent form by the patient or a proxy.

•1. patients with vasculitic ulcers
•2. patients requiring inpatient treatment for ulcers
•3. patients with severe anemia or thrombocytopenia
•4. patients with infection at the site of ulcer and tendency to exacerbation
•5. patients with malignant tumors at the ulcer site
•6. patients requiring surgical procedures such as amputation or skin grafting (not including debridement)
•7. patients receiving continuous oral or injectable steroid hormone therapy
•8. patients with severely impaired nutritional status
•9. patients undergoing dialysis or immunosuppression
•10. who has a history of allergy to adipose stem cell culture supernatant extract
•11. patients who have been deemed unsuitable by the principal investigator or a subinvestigator

发起方

akagawa Masahiro